Celldex Therapeutics CLDX Business Segments — Facility Cost

Similar metrics at other companies

OCULSingle Reportable — Facilities Expense

$2.27M+36.4%

QURESingle Reportable — Facility Expenses

$1.55M-7.2%

RGTISingle Reportable — Rent And Facilities

$2.12M+58.0%

ALMSSingle Reportable — Research And Development Facilities And Overhead Costs

$5.37M+3.5%

GRALReportable Segment — Facilities

$5.25M-6.8%

SIT

SITEReportable Segment — Facility expenses

$62.2M+4.2%

Questions, answered.

What is Celldex Therapeutics's business segments — facility cost?

Celldex Therapeutics (CLDX) reported business segments — facility cost of $1.33M in Q4 2025.

How has Celldex Therapeutics's business segments — facility cost changed year-over-year?

Celldex Therapeutics's business segments — facility cost increased by 4.1% year-over-year, from $1.27M to $1.33M.

What is the long-term trend for Celldex Therapeutics's business segments — facility cost?

Over 3 years (2022 to 2025), Celldex Therapeutics's business segments — facility cost has grown at a 3.6% compound annual growth rate (CAGR), from $4.76M to $5.3M.

What does business segments — facility cost mean?

This metric tracks the recurring costs associated with the physical facilities used for research and development operations within the primary business segment. It encompasses lease obligations, property taxes, and facility-related maintenance expenses. This metric is useful for evaluating the efficiency of the company's physical asset utilization in supporting its scientific goals.